Northern Trust Corp Arcutis Biotherapeutics, Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 976,070 shares of ARQT stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

976,070

Previous 991,056 1.51%

Holding current value

$14 Million

Previous $13.8 Million 10.58%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$11.4 - $17.29 $170,840 - $259,107	-14,986 Reduced 1.51%	976,070 $15.3 Million
Q4 2024 Feb 14, 2025	BUY	$8.31 - $14.99 $453,235 - $817,569	54,541 Added 5.82%	991,056 $13.8 Million
Q3 2024 Nov 13, 2024	BUY	$8.32 - $11.0 $1.54 Million - $2.03 Million	184,665 Added 24.56%	936,515 $8.71 Million
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $21,032 - $36,399	2,905 Added 0.39%	751,850 $6.99 Million
Q1 2024 May 14, 2024	BUY	$3.25 - $11.77 $59,153 - $214,225	18,201 Added 2.49%	748,945 $7.42 Million
Q4 2023 Feb 13, 2024	BUY	$1.84 - $4.82 $454,930 - $1.19 Million	247,245 Added 51.14%	730,744 $2.36 Million
Q3 2023 Nov 13, 2023	BUY	$5.31 - $10.98 $94,762 - $195,949	17,846 Added 3.83%	483,499 $2.57 Million
Q2 2023 Aug 11, 2023	BUY	$7.51 - $15.0 $591,727 - $1.18 Million	78,792 Added 20.37%	465,653 $4.44 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $20,552 - $34,434	2,009 Added 0.52%	386,861 $4.26 Million
Q4 2022 Feb 13, 2023	BUY	$13.96 - $20.4 $155,667 - $227,480	11,151 Added 2.98%	384,852 $5.7 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $1.05 Million - $1.58 Million	58,643 Added 18.61%	373,701 $7.14 Million
Q2 2022 Aug 12, 2022	BUY	$16.33 - $22.2 $916,455 - $1.25 Million	56,121 Added 21.67%	315,058 $6.71 Million
Q1 2022 May 13, 2022	SELL	$14.38 - $22.79 $158,410 - $251,054	-11,016 Reduced 4.08%	258,937 $4.99 Million
Q4 2021 Feb 08, 2022	SELL	$14.98 - $25.5 $8,478 - $14,433	-566 Reduced 0.21%	269,953 $5.6 Million
Q3 2021 Nov 15, 2021	SELL	$19.28 - $27.1 $377,579 - $530,726	-19,584 Reduced 6.75%	270,519 $6.46 Million
Q2 2021 Aug 13, 2021	BUY	$24.42 - $34.75 $568,619 - $809,153	23,285 Added 8.73%	290,103 $7.92 Million
Q1 2021 May 12, 2021	BUY	$24.47 - $36.98 $649,996 - $982,299	26,563 Added 11.06%	266,818 $7.72 Million
Q4 2020 Feb 11, 2021	BUY	$17.82 - $31.73 $534,368 - $951,487	29,987 Added 14.26%	240,255 $6.76 Million
Q3 2020 Nov 16, 2020	BUY	$23.44 - $32.28 $1.92 Million - $2.64 Million	81,938 Added 63.85%	210,268 $6.16 Million
Q2 2020 Aug 14, 2020	BUY	$24.48 - $36.56 $486,442 - $726,483	19,871 Added 18.32%	128,330 $3.88 Million
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $2.01 Million - $4 Million	108,459 New	108,459 $3.23 Million

Others Institutions Holding ARQT

# of Institutions

252

Shares Held

126M

Call Options Held

605K

Put Options Held

170K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $862M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Arcutis Biotherapeutics, Inc. Transaction History